STATEMENT OF CASH FLOWS	9 Months Ended
	Dec. 31, 2021 USD ($)
Cash flows from Operating Activities:
Net loss	$ (214,978)
Adjustments to reconcile net loss to net cash used in operating activities:
Formation cost paid by Sponsors	9,454
Interest earned on trust account	(1,030)
Change in fair value of over-allotment liability	60,000
Changes in current assets and liabilities
Prepaid expenses	(781,118)
Receivable from Sponsor	(276,000)
Accrued offering costs and expenses	117,578
Due to related party	12,000
Net cash used in operating activities	(1,074,094)
Cash flows from Investing Activities:
Principal deposited in Trust Account	(236,900,000)
Net cash used in investing activities	(236,900,000)
Cash flows from Financing Activities:
Proceeds from initial public offering, net of costs	225,400,000
Proceeds from sale of common stocks to initial shareholders	25,000
Proceeds from private placement	13,500,000
Proceeds from issuance of promissory note - related party	500,000
Payment of promissory note	(390,621)
Payment of deferred offering costs	(756,427)
Net cash provided by financing activities	238,277,952
Net change in cash	303,858
Cash, April 16, 2021 (inception)	0
Cash, end of the period	303,858
Supplemental disclosure of cash flow information:
Initial value of ordinary shares subject to possible redemption	236,900,000
Deferred underwriting commissions payable charged to additional paid in capital	8,050,000
Remeasurement of Class A ordinary shares to redemption value	26,703,555
Initial classification of over-allotment liabilities	$ 60,000